San Diego, California-based Aardvark Therapeutics, Inc. will make its trading debut on the Nasdaq Global Market, under the ticker symbol, "AARD" today, Feb. 13 , 2025.
This clinical-stage biopharmaceutical company, founded in 2017, is developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com